Hepatic allograft cyclosporine concentration is independent of the route of cyclosporine administration and correlates with the occurrence of early cellular rejection

W. J. Sandborn, G. M. Lawson, R. A F Krom, R. H. Wiesner

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

This study compares the hepatic-tissue cyclosporine concentrations in liver biopsy specimens from patients with and without cellular rejection after orthotopic liver transplantation. Nine patients without cellular rejection were studied, including five patients receiving intravenous cyclosporine who had biopsies on posttransplant day 7 and four patients receiving oral cyclosporine who had biopsies on day 21. In these patients no significant differences were seen in blood cyclosporine concentrations (mean ± S.D.) (310 ± 162 vs. 273 ± 310 ng/ml) and hepatic-tissue cyclosporine concentrations (3,451 ± 1,262 vs. 3,545 ± 456 ng/gm). These nine patients without cellular rejection were then compared with eight patients with cellular rejection who were receiving intravenous cyclosporine, including seven patients who had biopsies on posttransplant day 7 and one patient who had a biopsy on day 14. In patients with and without cellular rejection blood cyclosporine concentrations were 330 ± 64 vs. 294 ± 146 ng/ml, and hepatic- tissue cyclosporine concentrations were 1,879 ± 998 vs. 3,493 ± 936 ng/gm, p < 0.01. We conclude that hepatic-tissue cyclosporine concentrations are independent of the route of cyclosporine administration and that low hepatic- tissue cyclosporine concentrations correlate with early cellular rejection after orthotopic liver transplantation.

Original languageEnglish (US)
Pages (from-to)1086-1091
Number of pages6
JournalHepatology
Volume15
Issue number6
DOIs
StatePublished - 1992

Fingerprint

Cyclosporine
Allografts
Liver
Biopsy
Liver Transplantation

ASJC Scopus subject areas

  • Hepatology

Cite this

Hepatic allograft cyclosporine concentration is independent of the route of cyclosporine administration and correlates with the occurrence of early cellular rejection. / Sandborn, W. J.; Lawson, G. M.; Krom, R. A F; Wiesner, R. H.

In: Hepatology, Vol. 15, No. 6, 1992, p. 1086-1091.

Research output: Contribution to journalArticle

@article{27305165ee2146139857f329b2fde01f,
title = "Hepatic allograft cyclosporine concentration is independent of the route of cyclosporine administration and correlates with the occurrence of early cellular rejection",
abstract = "This study compares the hepatic-tissue cyclosporine concentrations in liver biopsy specimens from patients with and without cellular rejection after orthotopic liver transplantation. Nine patients without cellular rejection were studied, including five patients receiving intravenous cyclosporine who had biopsies on posttransplant day 7 and four patients receiving oral cyclosporine who had biopsies on day 21. In these patients no significant differences were seen in blood cyclosporine concentrations (mean ± S.D.) (310 ± 162 vs. 273 ± 310 ng/ml) and hepatic-tissue cyclosporine concentrations (3,451 ± 1,262 vs. 3,545 ± 456 ng/gm). These nine patients without cellular rejection were then compared with eight patients with cellular rejection who were receiving intravenous cyclosporine, including seven patients who had biopsies on posttransplant day 7 and one patient who had a biopsy on day 14. In patients with and without cellular rejection blood cyclosporine concentrations were 330 ± 64 vs. 294 ± 146 ng/ml, and hepatic- tissue cyclosporine concentrations were 1,879 ± 998 vs. 3,493 ± 936 ng/gm, p < 0.01. We conclude that hepatic-tissue cyclosporine concentrations are independent of the route of cyclosporine administration and that low hepatic- tissue cyclosporine concentrations correlate with early cellular rejection after orthotopic liver transplantation.",
author = "Sandborn, {W. J.} and Lawson, {G. M.} and Krom, {R. A F} and Wiesner, {R. H.}",
year = "1992",
doi = "10.1002/hep.1840150619",
language = "English (US)",
volume = "15",
pages = "1086--1091",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - Hepatic allograft cyclosporine concentration is independent of the route of cyclosporine administration and correlates with the occurrence of early cellular rejection

AU - Sandborn, W. J.

AU - Lawson, G. M.

AU - Krom, R. A F

AU - Wiesner, R. H.

PY - 1992

Y1 - 1992

N2 - This study compares the hepatic-tissue cyclosporine concentrations in liver biopsy specimens from patients with and without cellular rejection after orthotopic liver transplantation. Nine patients without cellular rejection were studied, including five patients receiving intravenous cyclosporine who had biopsies on posttransplant day 7 and four patients receiving oral cyclosporine who had biopsies on day 21. In these patients no significant differences were seen in blood cyclosporine concentrations (mean ± S.D.) (310 ± 162 vs. 273 ± 310 ng/ml) and hepatic-tissue cyclosporine concentrations (3,451 ± 1,262 vs. 3,545 ± 456 ng/gm). These nine patients without cellular rejection were then compared with eight patients with cellular rejection who were receiving intravenous cyclosporine, including seven patients who had biopsies on posttransplant day 7 and one patient who had a biopsy on day 14. In patients with and without cellular rejection blood cyclosporine concentrations were 330 ± 64 vs. 294 ± 146 ng/ml, and hepatic- tissue cyclosporine concentrations were 1,879 ± 998 vs. 3,493 ± 936 ng/gm, p < 0.01. We conclude that hepatic-tissue cyclosporine concentrations are independent of the route of cyclosporine administration and that low hepatic- tissue cyclosporine concentrations correlate with early cellular rejection after orthotopic liver transplantation.

AB - This study compares the hepatic-tissue cyclosporine concentrations in liver biopsy specimens from patients with and without cellular rejection after orthotopic liver transplantation. Nine patients without cellular rejection were studied, including five patients receiving intravenous cyclosporine who had biopsies on posttransplant day 7 and four patients receiving oral cyclosporine who had biopsies on day 21. In these patients no significant differences were seen in blood cyclosporine concentrations (mean ± S.D.) (310 ± 162 vs. 273 ± 310 ng/ml) and hepatic-tissue cyclosporine concentrations (3,451 ± 1,262 vs. 3,545 ± 456 ng/gm). These nine patients without cellular rejection were then compared with eight patients with cellular rejection who were receiving intravenous cyclosporine, including seven patients who had biopsies on posttransplant day 7 and one patient who had a biopsy on day 14. In patients with and without cellular rejection blood cyclosporine concentrations were 330 ± 64 vs. 294 ± 146 ng/ml, and hepatic- tissue cyclosporine concentrations were 1,879 ± 998 vs. 3,493 ± 936 ng/gm, p < 0.01. We conclude that hepatic-tissue cyclosporine concentrations are independent of the route of cyclosporine administration and that low hepatic- tissue cyclosporine concentrations correlate with early cellular rejection after orthotopic liver transplantation.

UR - http://www.scopus.com/inward/record.url?scp=0026697204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026697204&partnerID=8YFLogxK

U2 - 10.1002/hep.1840150619

DO - 10.1002/hep.1840150619

M3 - Article

C2 - 1592348

AN - SCOPUS:0026697204

VL - 15

SP - 1086

EP - 1091

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 6

ER -